tirzepatide vs semaglutide

Tirzepatide Tops Semaglutide in Real-World Weight Loss — Photo by Alena Shekhovtcova on Pexels

Tirzepatide Achieves 13% Prescription Weight Loss vs Semaglutide

Tirzepatide Achieves 13% Prescription Weight Loss vs Semaglutide Tirzepatide delivers a 13% total body weight loss, about 2 percentage points more than semaglutide, in real-world data over 24 months. The difference reflects higher adherence and the drug’s dual GLP-1/GIP action, offering a measurable edge for clinicians seeking durable

Tirzepatide outperformed semaglutide weight-loss drug results in real world patients, study shows — Photo by Julia Larson on

tirzepatide real‑world

Prescription Weight Loss Fails Tirzepatide Triumphs Instead

Tirzepatide delivered markedly greater weight loss than older GLP-1 agents in 2023, translating into superior blood-glucose control and a milder side-effect profile. This outcome challenges the modest results of conventional prescription weight-loss drugs, which often fail to sustain metabolic benefits over time. Medical Disclaimer: This article is for informational purposes